1.1Bacterial production host
A bacterial production strain expresses enzymes that convert a tryptophan-derived precursor into the target alkaloid. A stirred bioreactor supplies oxygen and controls the pH of the bacterial culture.
Generated automatically. Not reviewed by a person. Not legal advice or an opinion.
Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.
A bacterial production strain expresses enzymes that convert a tryptophan-derived precursor into the target alkaloid. A stirred bioreactor supplies oxygen and controls the pH of the bacterial culture.
Purified enzymes catalyze the conversion of the precursor in a buffered reaction vessel. A membrane retains the enzymes while the dissolved product passes into a collection vessel.
The full culture transfers from the vessel to a freeze dryer without a clarification step. Water leaves by sublimation, and the dried solids retain the product along with the biomass and residual nutrients.
A reaction vessel brings the intermediate together with chemical reagents that form the target molecule. Downstream purification separates the product from unreacted intermediates and reaction byproducts.
Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.
An analytical laboratory cultures the fungus in separate vessels to prepare samples for checking alkaloid recovery from fungal growth media. A bench centrifuge separates each harvested culture into a solids pellet and a clarified liquid, and the laboratory retains the fraction containing the target alkaloid. The laboratory dispenses that fraction into single-use vials and analyzes one vial per batch to assign a concentration for subsequent recovery checks.
An agar-solidified nutrient medium replaces the liquid growth medium, and a sterile porous cellulose membrane covers its surface. Fungal material grows on the membrane while dissolved nutrients diffuse upward from the agar. At harvest, forceps lift the membrane and attached biomass from the medium, and a separate assay of the spent agar measures the alkaloid retained in the medium.
Twelve 250 mL vented culture vessels each contain 50 mL of growth medium and receive equal aliquots of a mixed fungal inoculum. A rack holds the vessels under common incubation conditions and provides 200 mL of nominal headspace per vessel. At harvest, a bench centrifuge separates the solids and liquid from each vessel, and the operator pools the corresponding fractions after measuring alkaloid concentration in each.
A stirred culture vessel connects to a hollow-fiber microfiltration module through a sanitary pump and a return line. During harvest, culture liquid circulates through the fiber lumens while clarified permeate passes through the fiber walls into a collection vessel. A second outlet transfers the concentrated fungal solids to a separate vessel, and alkaloid measurements determine which stream proceeds to further separation.
A solids filter feeds clarified culture liquid to a cartridge containing a polymeric solid-phase extraction sorbent. A metering pump moves the liquid through the cartridge at a fixed flow rate, and outlet samples track breakthrough of the target alkaloid. After loading, a wash removes residual medium components and an eluent releases the retained alkaloid into a separate collection vessel.
A sterile sampling valve connects the culture vessel to an automated sampler that fills a vial at each programmed interval. Liquid chromatography measures alkaloid concentration in a filtered aliquot and sends the result to a controller. Once the measured concentration meets a preset threshold and successive readings fall within a configured tolerance, the controller opens the harvest valve and transfers the culture to a separator.
A compatible plant and fungus form a root association in which the plant supplies carbon compounds to the fungus. The harvested colonized roots contain fungal biomass and its metabolites.
Fungal material grows at the air–liquid interface in a shallow vessel containing an aqueous nutrient medium. A perforated support lifts the mycelial mat and lets free liquid drain back into the vessel.
A stirred vessel suspends fungal biomass in a liquid nutrient medium. A gas sparger supplies air, and a dissolved oxygen probe measures oxygen in the broth.
A filter removes suspended fungal solids before the clarified broth enters a packed resin column. The resin retains the dissolved alkaloid, and a separate elution stream carries it into a collection vessel.
Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.
A method for producing cell aggregates includes culturing cells while suspending the cells in a liquid culture medium comprising a lysophospholipid.A · US 2017/0327779 A1 · abstract
The term “perfusion bioreactor” means a bioreactor containing a plurality of cells (e.g., mammalian cells) in a first liquid culture medium, wherein the culturing of the cells present in the bioreactor includes periodic or continuous removal of the first liquid culture medium and at the same time or shortly thereafter adding substantially the same volume of a second liquid culture medium to the bioreactor.B · US 2022/0333054 A1 · ¶ 63
An empty cell means only that no passage was reproduced there.
One of objectives directed toward practical use of regenerative medicine in which pluripotent stem cells are used to regenerate a variety of organs involves how a large number of cells necessary for regeneration of organs can be produced efficiently.A · US 2017/0327779 A1 · ¶ 3
It is easy to scale up suspension culture in which cells are cultured in suspension in a liquid culture medium.A · US 2017/0327779 A1 · ¶ 4
In the current environment of diverse product pipelines, biotechnology companies are increasingly driven to develop innovative solutions for highly flexible and cost-effective manufacturing of therapeutic protein drug substances.B · US 2022/0333054 A1 · ¶ 3
In some embodiments of any of the methods described herein, the method includes adjusting one or both of the pH and the pCO2 of the first and second liquid culture medium in the vessel at some point during the period of time.B · US 2022/0333054 A1 · ¶ 8
patent.fyi, US 2026/0354317 A1, claim 1, first published 2026-11-18T21:18:11-05:00, https://patent.fyi/US20260354317/, SHA-256 783ae63b48801b431f1c337f58921db8f239f0eeaaf59a81cc1e87e8e5eb45cd